Beaton Management Company’s Elevance Health ELV Stock Holding History

Beaton Management Company’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-800	Closed	-$393K	–	132
2022 Q1	$393K	Hold	800	–	–	0.24%	92
2021 Q4	$371K	Hold	800	–	–	0.22%	97
2021 Q3	$298K	Hold	800	–	–	0.2%	107
2021 Q2	$305K	Hold	800	–	–	0.19%	109
2021 Q1	$287K	Hold	800	–	–	0.2%	110
2020 Q4	$257K	Hold	800	–	–	0.19%	108
2020 Q3	$215K	Hold	800	–	–	0.18%	113
2020 Q2	$210K	Buy	+800	New	+$213K	0.19%	106
2020 Q1	–	Sell	-800	Closed	-$242K	–	109
2019 Q4	$242K	Buy	+800	New	+$220K	0.19%	108
2019 Q3	–	Sell	-800	Closed	-$226K	–	119
2019 Q2	$226K	Hold	800	–	–	0.19%	109
2019 Q1	$230K	Hold	800	–	–	0.2%	108
2018 Q4	$210K	Hold	800	–	–	0.21%	107
2018 Q3	$219K	Buy	+800	New	+$208K	0.18%	115

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Beaton Management Company's ELV Position: Q2 2022 in Review

Beaton Management Company sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 800 shares — an estimated $393K sold.

Beaton Management Company first reported a position in ELV in Q3 2018 and held it in 13 quarters. The position peaked at $393K in Q1 2022. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

Beaton Management Company reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
Beaton Management Company sold 800 Elevance Health shares in Q2 2022, an estimated $393K.
Beaton Management Company first reported a position in Elevance Health in Q3 2018 and held it in 13 quarters.
Beaton Management Company's Elevance Health position peaked at $393K in Q1 2022.
1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Beaton Management Company's 13F filing for Q2 2022, filed 12 Aug 2022.